Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy

Cancer Marker Profile - Female

Also referred as
Female Cancer Panel
+2
Female Tumor Marker Panel
Cancer Panel for Females
xyz people viewed recently
1,140+ booked recently
For women
Earliest reports in
48 hours
Contains
29 tests
Package price:
₹3619
₹5040
28% off
Know when you'll get your report
For sample collection between
6 AM - 1 PM
1 PM - 4 PM
4 PM - 10 PM
Reporting in
48hrs
discount_stamp
More offers available
Know more about this test
<font color='#864291'>Know more about this test</font>

The Cancer Marker Profile - Female is a comprehensive female cancer marker package designed to support risk assessment, diagnosis support, and long-term monitoring of selected malignancies. The panel includes Alpha Feto protein (AFP), CA 15.3, CA 19.9, Carcino embryonic Antigen (CEA), Thyroglobulin, CA 125, Lactate Dehydrogenase (LDH), CBC (Complete Blood Count), and ESR (Erythrocyte Sedimentation Rate) tests. It measures multiple tumor markers and hematological parameters that help detect potential malignancy, assess disease burden, and monitor treatment response or recurrence, when interpreted alongside other clinical findings.

Samples required
Blood
Find out
Why is this package booked?
Preparation for this package
Sample Collection
Who will collect your samples?
Conducted by
know_more_icon
Tata 1mg Labs
chevron
most trusted lab
Accredited labs
Highly skilled Phlebos
Verified reports
Who will collect your samples?
Tata 1mg certified phlebotomists
View phlebo details

Understanding Cancer Marker Profile - Female

The Cancer Marker Profile - Female comprises a combination of tumor markers and routine blood tests that provide valuable information about abnormal tumor cell activity, organ involvement, and overall health status. Tumor markers are substances produced either by cancer cells or by the body in response to cancer. While they are not diagnostic on their own, abnormal levels can support clinical findings and imaging results.

The Cancer Marker Profile - Female includes tumor markers such as Alpha Feto Protein (AFP), CA 15.3, CA 19.9, CEA, Thyroglobulin, and CA 125, which are associated with cancers of the liver, breast, ovaries, gastrointestinal tract, and thyroid and may support risk assessment and monitoring in female health screening. Lactate Dehydrogenase (LDH) is a non-specific marker that may increase with tissue damage or rapidly growing tumors, while the CBC and ESR provide insight into anemia, infection, inflammation, or bone marrow involvement.

This panel may be recommended for individuals with symptoms suggestive of cancer, such as unexplained weight loss, persistent fatigue, abnormal bleeding, pain, or swelling. It is also useful for individuals with a known cancer diagnosis to monitor disease progression, assess treatment response, or detect recurrence after successful treatment. In some cases, it may be advised for individuals with a strong family history of cancer or other high-risk factors.

Provide a brief clinical history/doctor's prescription at the time of sample collection. Inform your doctor about all your medications, as some can affect the test results, potentially requiring dosage adjustments or temporary discontinuation. The test should not be done immediately before or during menstruation or immediately after abdominal surgery, as these cause transiently increased CA 125 levels. Pregnancy may also affect the levels of CA 125. Test result ranges are approximate and may vary between laboratories depending on the methodology and reference standards.

This package is intended for clinical support and disease monitoring only and is not meant for population-based cancer screening or definitive diagnosis. Tumor markers may be influenced by benign conditions, physiological states, medications, or non-malignant diseases, and normal values do not exclude the presence of cancer. Results must always be interpreted by a qualified clinician in conjunction with medical history, physical examination, imaging studies, and, when indicated, histopathological confirmation. This test should not replace recommended cancer screening methods such as mammography, Pap smear, HPV testing, colonoscopy, or imaging-based evaluations.

See more

What does Cancer Marker Profile - Female measure?

Contains 29 tests

The Cancer Marker Profile - Female measures levels of several tumor markers and hematological parameters like CBC (Complete Blood Count) and ESR (Erythrocyte Sedimentation Rate) in the blood. The tumor markers include: 

Alpha Feto Protein (AFP), Tumour Marker: It is associated with liver cancer and certain germ cell tumors, but levels may also increase in chronic liver diseases such as hepatitis or cirrhosis, limiting specificity. 

CA 15.3: It is primarily linked to breast cancer and may help in monitoring disease progression or recurrence. However, it has limited sensitivity for early detection and may be elevated in benign liver or inflammatory conditions. 

CA 19.9: It is associated with pancreatic and other gastrointestinal cancer, but levels may also rise in benign conditions such as pancreatitis, cholestasis, or liver disease, and some individuals do not produce CA 19-9 due to Lewis antigen negativity. 

Carcino embryonic Antigen (CEA): It is commonly linked with colorectal and other gastrointestinal cancers and is often used to monitor disease progression. However, it may be elevated in smokers and benign conditions such as inflammatory bowel disease, liver disease, or pancreatitis. 

Thyroglobulin: It is produced by thyroid tissue and is mainly used for monitoring differentiated thyroid cancer after treatment. However, it is not suitable for primary screening and may be affected by thyroid disorders or anti-thyroglobulin antibodies. 

CA 125: It may support evaluation and monitoring of ovarian cancer, but it may also be elevated in benign conditions such as endometriosis, menstruation, pelvic inflammatory disease, and pregnancy.

These parameters cannot be used as population screening tools because tbecause their levels may remain normal despite early malignancy and may increase in non-malignant conditions. These tests require imaging and histopathology to confirm cancer. When interpreted alongside clinical findings and imaging studies, the Cancer Marker Profile - Female provides valuable support for disease monitoring, treatment assessment, and informed cancer management in women.

The CBC (Complete Blood Count) test measures the number of red blood cells (RBCs), white blood cells (WBCs), and platelets. Each of these blood cells performs essential functions–RBCs carry oxygen from your lungs to the various body parts, WBCs help fight infections and other diseases, and platelets help your blood to clot. Therefore, determining their levels can provide significant health information. A CBC test also determines the hemoglobin level, a protein in RBC that carries oxygen from the lungs to the rest of your body. Evaluating all these components together can provide important information about your overall health.

Know more about CBC (Complete Blood Count)

  • Differential Leukocyte Count

  • There are five types of WBCs: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. A Differential Leukocyte Count test measures the percentage of each type of WBC in the blood. Leukocytes or WBCs are produced in the bone marrow and defend the body against infections and diseases. Each type of WBC plays a unique role to protect against infections and is present in different numbers.

    This further contains

    • Differential Neutrophil Count
    • Differential Lymphocyte Count
    • Differential Monocyte Count
    • Differential Eosinophil Count
    • Differential Basophil Count
  • Red Blood Cell Count

  • The Red Blood Cell Count test measures the total number of red blood cells in your blood. RBCs are the most abundant cells in the blood with an average lifespan of 120 days. These cells are produced in the bone marrow and destroyed in the spleen or liver. Their primary function is to help carry oxygen from the lungs to different body parts. The normal range of RBC count can vary depending on age, gender, and the equipment and methods used for testing.

  • Hb (Hemoglobin)

  • The Hb (Hemoglobin) test measures the concentration of hemoglobin in your blood. Hemoglobin binds oxygen molecules and carries them to body tissues while removing carbon dioxide. Low hemoglobin suggests reduced oxygen-carrying capacity. It can be due to anemia, bleeding, nutritional deficiencies (iron, vitamin B12, folate), or chronic disease. High hemoglobin may occur in dehydration, living at high altitudes, smoking, or diseases like polycythemia vera.

  • Platelet Count

  • The Platelet Count test measures the average number of platelets in the blood. Platelets are disk-shaped tiny cells originating from large cells known as megakaryocytes, which are found in the bone marrow. After the platelets are formed, they are released into the blood circulation. Their average life span is 7-10 days. 

    Platelets help stop the bleeding, whenever there is an injury or trauma to a tissue or blood vessel, by adhering and accumulating at the injury site and releasing chemical compounds that stimulate the gathering of more platelets. A loose platelet plug is formed at the site of injury and this process is known as primary hemostasis. These activated platelets support the coagulation pathway that involves a series of steps, including the sequential activation of clotting factors; this process is known as secondary hemostasis. After this step, there is a formation of fibrin strands that form a mesh incorporated into and around the platelet plug. This mesh strengthens and stabilizes the blood clot so that it remains in place until the injury heals. After healing, other factors come into play and break the clot down so that it gets removed. In case the platelets are not sufficient in number or not functioning properly, a stable clot might not form. These unstable clots can result in an increased risk of excessive bleeding. 

  • Total Leukocyte Count

  • The Total Leukocyte Count test measures the numbers of all types of leukocytes, namely neutrophil, lymphocyte, monocyte, eosinophil, and basophil, in your blood. Leukocytes or WBCs are an essential part of our immune system. These cells are produced in the bone marrow and defend the body against infections and diseases. Each type of WBC plays a unique role to protect against infections and is present in different numbers.

  • Hematocrit

  • The Hematocrit test measures the proportion of red blood cells (RBCs) in your blood as a percentage of the total blood volume. It is a crucial part of a complete blood count (CBC) and helps in assessing your blood health. RBCs are responsible for carrying oxygen from the lungs to different parts of the body. The hematocrit test provides valuable information about your blood's oxygen-carrying capacity.

    Higher-than-normal amounts of RBCs produced by the bone marrow can cause the hematocrit to increase, leading to increased blood density and slow blood flow. On the other hand, lower-than-normal hematocrit can be caused by low production of RBCs, reduced lifespan of RBCs in circulation, or excessive bleeding, leading to a reduced amount of oxygen being transported by RBCs. Monitoring your hematocrit levels is essential for diagnosing and managing various blood-related disorders.

  • Mean Corpuscular Volume

  • The Mean Corpuscular Volume test measures the average size of your red blood cells, which carry oxygen through your body. This test tells whether your RBCs are of average size and volume or whether they are bigger or smaller.

  • Mean Corpuscular Hemoglobin

  • An MCH test measures the average amount of hemoglobin in a single red blood cell (RBC). Hemoglobin is an iron-containing protein in RBCs, and its major function is to transport oxygen from the lungs to all body parts. This test provides information about how much oxygen is being delivered to the body by a certain number of RBCs.

  • Mean Corpuscular Hemoglobin Concentration

  • An MCHC test measures the average amount of hemoglobin in a given volume of RBCs. MCHC is calculated by dividing the amount of hemoglobin by hematocrit (volume of blood made up of RBCs) and then multiplying it by 100. 

  • Absolute Leucocyte Count

  • The Absolute Leucocyte Count test measures the total number of white blood cells (leucocytes) in the given volume of blood. It examines different types of white blood cells such as neutrophils, lymphocytes, monocytes, basophils and eosinophils. These cells tell about the status of the immune system and its ability to fight off infections and other conditions like inflammation, allergies, bone marrow disorders etc.

    This further contains

    • Absolute Lymphocyte Count (ALC)
    • Absolute Neutrophil Count
    • Absolute Basophil Count
    • Absolute Monocyte Count
    • Absolute Eosinophil Count
  • Mean Platelet Volume

  • An MPV test measures the average size of the platelets in your blood. Platelets are disk-shaped tiny cells originating from large cells known as megakaryocytes, which are found in the bone marrow. After the platelets are formed, they are released into the blood circulation. Their average life span is 7-10 days. 

    Platelets help stop bleeding whenever there is an injury or trauma to a tissue or blood vessel by adhering and accumulating at the injury site, and by releasing chemical compounds that stimulate the gathering of more platelets. After these steps, a loose platelet plug is formed at the site of injury, and this process is known as primary hemostasis. These activated platelets support the coagulation pathway that involves a series of steps including the sequential activation of clotting factors; this process is known as secondary hemostasis. After this, there is a formation of fibrin strands that form a mesh incorporated into and around the platelet plug. This mesh strengthens and stabilizes the blood clot so that it remains in place until the injury heals. After healing, other factors come into play and break the clot down so that it gets removed. In case the platelets are not sufficient in number or are not functioning properly, a stable clot might not form. These unstable clots can result in an increased risk of excessive bleeding. 

  • PDW

  • The PDW test reflects variability in platelet size, and is considered a marker of platelet function and activation (clot formation in case of an injury). This marker can give you additional information about your platelets and the cause of a high or low platelet count. Larger platelets are usually younger platelets that have been recently released from the bone marrow, while smaller platelets may be older and have been in circulation for a few days. Higher PDW values reflect a larger range of platelet size, which may result from increased activation, destruction and consumption of platelets.

  • RDW CV

  • The RDW CV test which is part of red cell indices, helps identify characteristics of red blood cells. RDW (red cell distribution width) measures the variations in the sizes of red blood cells, indicating how much they differ from each other in a blood sample. RDW is expressed as RDW-CV, a coefficient of variation. A higher RDW may suggest more variation in red cell sizes, while a lower RDW indicates more uniform red cell sizes.

The ESR (Erythrocyte Sedimentation Rate) test measures how fast red blood cells (erythrocytes) settle in a tube over one hour.

When your body is inflamed, certain proteins, mainly fibrinogen, increase in the blood. These proteins cause the red blood cells to stick together in stacks. These stacks settle faster, leading to a higher ESR.

The ESR test shows that inflammation is present. However, it cannot tell you exactly where the inflammation is or what is causing it. That’s why doctors usually do this test along with other tests. This helps them understand and treat your health problems.

Know more about ESR (Erythrocyte Sedimentation Rate)

The Lactate Dehydrogenase, Serum test measures the level of the enzyme lactate dehydrogenase (LDH) in the blood. LDH is involved in energy production and is present in many types of cells, including those in the heart, liver, muscles, kidneys, brain, and blood cells. When these cells are damaged or destroyed, they release LDH into the bloodstream. Therefore, a minor amount of LDH is continuously released into the bloodstream as part of regular cell turnover and metabolic processes. However, elevated LDH is concerning because it usually signals underlying tissue damage, inflammation, or a wide range of diseases such as liver disease, heart disease, hemolytic anemia, and certain cancers. Its elevation necessitates further diagnostic evaluation to determine the specific cause and appropriate treatment.

Know more about Lactate Dehydrogenase, Serum

CA125 is a protein found in most ovarian cancer cells and some normal tissues. A CA125 (Cancer Antigen 125) test is commonly advised to detect ovarian cancer by measuring the amount of CA125 protein in the blood. A deranged level of CA125 antigen may indicate the presence of certain cancers, primarily ovarian cancer or other non-cancerous conditions, including endometriosis, pelvic inflammatory disease, ovarian cysts, etc.

Know more about CA125 (Cancer Antigen 125)

The CA15.3 test measures the amount of Cancer Antigen 15.3 in your blood. It is a protein that is often elevated in the blood of individuals with breast cancer. Therefore, CA15.3 is an important tool in monitoring the progress of breast cancer treatment and checking for recurrence.

To make a precise diagnosis, healthcare advisors recommend the CA15.3 test results in conjunction with other blood tests and diagnostic imaging tests. Individuals undergoing the CA15.3 test should discuss the results with their healthcare provider to gain a comprehensive understanding of their cancer status and make informed decisions about their treatment plan.

Know more about CA15.3

The Thyroglobulin test measures the level of thyroglobulin, a protein that serves as a precursor in the production of the thyroid hormones thyroxine (T4) and triiodothyronine (T3). This protein is produced only by the thyroid gland and by thyroid cancer cells if they are present.

After the thyroid gland has been surgically removed or ablated with radioactive iodine, thyroglobulin levels should ideally be very low or undetectable. Any detectable or rising levels of thyroglobulin in this context may indicate a recurrence of thyroid cancer or the presence of residual thyroid tissue.

A positive thyroglobulin test result, indicating high or increasing levels, suggests that thyroid cancer cells may still be present or have recurred, prompting further testing and potentially additional treatment. This test plays a crucial role in the long-term monitoring and management of patients treated for thyroid cancer.

Know more about Thyroglobulin

The Carcino Embryonic Antigen test measures the level of a specific tumor marker called CEA In the blood, often associated with colon and rectal cancer. This biomarker is produced by certain tissues in the body, specifically gastrointestinal tissues, during fetal development. CEA levels drop to low or nonexistent levels after birth. Elevated levels of CEA in the blood may indicate the presence of certain cancers, particularly colorectal cancer. However, it's important to note that high CEA levels can also be linked to non-cancerous conditions.

For a comprehensive evaluation, it is advised to consider other diagnostic tests in conjunction with Carcino Embryonic Antigen test and consult a doctor for a proper understanding of the test results.

Know more about Carcino Embryonic Antigen

An Alpha Feto Protein, Tumour Marker test that measures the level of AFP (alpha-fetoprotein) in your blood sample. Alpha-fetoprotein is a protein produced by the liver of a developing baby (fetus). AFP circulates through the fetal and maternal blood. It is present during pregnancy but disappears rapidly after birth. However, elevated AFP levels in adults can be a sign of liver disease, liver cancer, or cancers of the testes or ovaries. An Alpha Feto Protein, Tumour Marker can also be used for assessing response to ongoing treatment and monitoring for cancer recurrence.

Know more about Alpha Feto Protein, Tumour Marker

A CA19.9 test measures the level of a specific tumor marker called CA 19.9 in the blood, often associated with gastrointestinal cancers, particularly pancreatic cancer. This biomarker is produced by certain cells in the body, specifically epithelial cells. These cells are found in various tissues, including the gastrointestinal tract. Elevated levels of CA 19.9 are often associated with cancers that involve these tissues, such as pancreatic, colorectal, and gastric cancers. However, CA 19.9 can also be produced by non-cancerous conditions, impacting its specificity as a diagnostic marker. For a comprehensive evaluation, it is advised to consider other diagnostic tests in conjunction with a CA19.9 test and consult a doctor for a proper understanding of the test results.

Know more about CA19.9

Did you find information useful ?
yesYES (3)
noNO

Cancer Marker Profile - Female test price for other cities

Price inMumbaiRs. 3619
Price inBangaloreRs. 3619
Price inNew DelhiRs. 3619
Price inPuneRs. 3619
Price inKolkataRs. 3619
Book a Cancer Marker Profile - Female test at home near me
Easy online booking
Easy online booking
Search for tests and packages, book your preferred time slot and enter your address for seamless at-home lab tests.
Live tracking of phlebotomist
Live tracking of phlebotomist
Track our trained phlebotomist's real time location for seamless sample collection.
Safe Sample Collection
Safe Sample Collection
Our phlebotomists follow strict safety protocols to collect samples safely at home and on time.
Sample received at lab
Sample received at lab
Samples are transported securely to our accredited labs with world-class machines for testing by qualified experts.
Quick, Doctor-Verified Reports
Quick, Doctor-Verified Reports
Get doctor-approved reports via email and WhatsApp, with options for doctor follow-ups and AI insights.

FAQs related to Cancer Marker Profile - Female

The Cancer Marker Profile - Female is designed to support the diagnosis of, and monitor various cancers in females by measuring tumor markers and blood parameters.
Overnight fasting is not required for this test. You can eat and drink normally.
A blood sample is collected from a vein in the arm and analyzed in a laboratory.
The test is generally safe. Minor discomfort, bruising, or swelling may occur at the blood collection site.
It is recommended by doctors when you have symptoms suggestive of cancer, a known cancer diagnosis requiring monitoring, or a strong family history of cancer.
Elevated levels may indicate cancer, disease progression, or recurrence, but can also occur in non-cancerous conditions.
No. This panel only supports the diagnosis of cancer but cannot confirm cancer on its own. Further tests, such as imaging or biopsy, may be required.
Doctors may recommend imaging studies (CT, MRI, PET scan), biopsies, organ-specific function tests, or additional tumor markers depending on the clinical scenario.
Tata 1mg ensures accurate lab test results through certified laboratories that use advanced technology and adhere to stringent quality control measures. This commitment to high standards guarantees reliable results.
Package contains 29 tests
Samples required
Preparations
Why is this package booked?
Available Offers